Please assess the completion status of the following clinical trial:

Trial Title: Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 18 - 65 years old~* Moderate pain defined as 4-6 out of 10, severe pain defined as ≥ 7 out of 10 as defined by the numeric rating pain scale (NRS)~* Proficient in reading and understanding English~* Are deemed by the attending physician to require opioid therapy.~Exclusion Criteria:~* Inability to give consent,~* Inability to use the numeric rating scale (NRS) score~* Long-term use of opioids, history of chronic pain~* Known substance abuse known as excessive use of a drug such as (e.g. alcohol, narcotics or cocaine)~* Known hypersensitivity to ketamine or fentanyl~* Pregnancy~* Alcohol intoxication~* Depression~* Anxiety~* Chronic obstructive pulmonary disease~* Asthma~* Cirrhosis~* On dialysis~* Acute ischemic stroke~* Heart rate (HR) less \< 60 bpm or \> 120 bpm~* Systolic blood pressure (SBP) \< 90 mmHg or \> 180 mmHg~* Ischemic heart disease~* Ketamine prior to arrival~* Trauma patients~* Sepsis or septic shock~* Weight \> 100 kg.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Sub-Dissociative Ketamine alone (Type: ACTIVE_COMPARATOR): 0.3 mg/kg of Sub-Dissociative Ketamine IV administered over at least 1 minute
- Fentanyl alone (Type: ACTIVE_COMPARATOR): 1 mg/kg of Fentanyl IV administered over at least 1 minute
- Sub-dissociative Ketamine and Fentanyl (Type: EXPERIMENTAL): Combined dose of 0.15 mg/kg of Sub-dissociative Ketamine and 0.5 mg/kg of Fentanyl IV administered over at least 1 minute

Based on this trial design, predict the completion outcome and termination type (if applicable).